Lack of an Effect of Ritonavir Alone and Lopinavir-Ritonavir on the Pharmacokinetics of Fenofibric Acid in Healthy Volunteers

Pharmacotherapy
Lori A GordonScott R Penzak

Abstract

Because we previously observed a significant 41% reduction in gemfibrozil exposure after 2 weeks of lopinavir-ritonavir administration, we sought to determine the influence of lopinavir-ritonavir and ritonavir alone on the pharmacokinetics of fenofibric acid, an alternative to gemfibrozil for the treatment of elevated triglyceride levels. Open-label, single-sequence pharmacokinetic study. Clinical Research Center at the National Institutes of Health. Thirteen healthy adult volunteers. Subjects received a single oral dose of fenofibrate 145 mg during three study phases: before ritonavir administration, after 2 weeks of administration of ritonavir 100 mg twice/day, and after 2 weeks of administration of lopinavir 400 mg-ritonavir 100 mg twice/day. Serial blood samples were collected over 120 hours for determination of fenofibric acid concentrations. Fenofibric acid pharmacokinetic parameter values were compared before and after concomitant ritonavir or lopinavir-ritonavir administration. The geometric mean ratios (90% confidence intervals) for fenofibric acid area under the plasma concentration-time curve were 0.89 (0.77-1.01) after 14 days of ritonavir alone compared with baseline (p>0.05) and 0.87 (0.69-1.05) after 14 days of l...Continue Reading

References

Jan 1, 1989·Cardiology·J Caldwell
Sep 2, 1998·British Journal of Clinical Pharmacology·D OuelletG R Granneman
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Nov 16, 2001·Revista Panamericana De Salud Pública = Pan American Journal of Public Health·UNKNOWN Panel on Clinical Practices for Treatment of HIV infection
Aug 28, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Carl Grunfeld, Phyllis Tien
Dec 31, 2003·Biochemical Pharmacology·Manuela EhrhardtJohanna Weiss
Jan 20, 2004·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Scott R Penzak, Susan K Chuck
Apr 12, 2005·AIDS·Daniel S Kamin, Steven K Grinspoon
Dec 1, 2005·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·M YamazakiJ H Lin
Aug 8, 2006·Clinical Pharmacology and Therapeutics·Manon J van der LeeDavid M Burger
Sep 24, 2008·Expert Opinion on Investigational Drugs·Theodosios Filippatos, Haralampos J Milionis
Mar 5, 2009·Annals of Internal Medicine·Michael J SilverbergMichael A Horberg
Jul 30, 2009·The Open AIDS Journal·Erika Ferrari Rafael da Silva, Giuseppe Bárbaro
Aug 4, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Kristin H BusseScott R Penzak
Jul 8, 2010·Expert Opinion on Drug Metabolism & Toxicology·Divya Samineni, Carl J Fichtenbaum
Mar 29, 2011·The American Journal of Drug and Alcohol Abuse·R Douglas BruceGerald H Friedland
Nov 22, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Valerie A GruberElinore F McCance-Katz
Jan 9, 2013·Clinical Biochemistry·M DuroI Rebelo
Apr 16, 2013·Revista da Associação Médica Brasileira·Suelen Jorge SouzaPatrícia Helen Carvalho Rondó
Jul 19, 2014·Journal of Psychiatric Practice·David McMahon, Sheldon H Preskorn

❮ Previous
Next ❯

Citations

Dec 21, 2016·Clinical and Translational Science·R A Farris, E T Price
Feb 20, 2020·Antimicrobial Agents and Chemotherapy·Helena RabiePaolo Denti
Sep 13, 2019·Expert Opinion on Drug Metabolism & Toxicology·Maria Del Mar GutierrezPere Domingo
Sep 13, 2020·Cardiovascular Drugs and Therapy·Shubham Agarwal, Sanjeev Kumar Agarwal
Oct 13, 2020·Atherosclerosis·Zohaib IqbalUNKNOWN Heart UK's Medical Scientific and Research Committee

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.